CRVO
Price:
$9.06
Market Cap:
$83.83M
CervoMed Inc., a clinical-stage biotechnology company, engages in the development and commercialization of drug treatments for neurodegenerative diseases. It develops neflamapimod, an orally administered small molecule brain penetrant for the treatment of dementia with Lewy bodies (DLB), Alzheimer's diseases, and brain stroke recovery. The company is based in Boston, Massachusetts.
Industry
Biotechnology
IPO Date
2008-05-23
Stock Exchange
NASDAQ
Ticker
CRVO
According to CervoMed Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -3.12. This represents a change of -9.29% compared to the average of -3.44 of the last 4 quarters.
The mean historical PE Ratio of CervoMed Inc. over the last ten years is -3.20. The current -3.12 PE Ratio has changed 9.64% with respect to the historical average. Over the past ten years (40 quarters), CRVO's PE Ratio was at its highest in in the September 2023 quarter at 1.78. The PE Ratio was at its lowest in in the June 2016 quarter at -53.93.
Average
-3.20
Median
-1.27
Minimum
-10.76
Maximum
-0.26
Discovering the peaks and valleys of CervoMed Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 1.28%
Maximum Annual PE Ratio = -0.26
Minimum Annual Increase = -96.74%
Minimum Annual PE Ratio = -10.76
| Year | PE Ratio | Change |
|---|---|---|
| 2024 | -1.16 | -87.60% |
| 2023 | -9.35 | 1.28% |
| 2022 | -0.68 | -46.06% |
| 2021 | -1.26 | -58.62% |
| 2020 | -3.04 | 1.06% |
| 2019 | -0.26 | -25.56% |
| 2018 | -0.35 | -96.74% |
| 2017 | -10.76 | 739.30% |
| 2016 | -1.28 | -67.12% |
| 2015 | -3.90 | -88.14% |
The current PE Ratio of CervoMed Inc. (CRVO) is greater than its 3-year, less than than its 5-year, and greater than its 10-year historical averages
3-year avg
-3.73
5-year avg
-3.10
10-year avg
-3.20
CervoMed Inc.’s PE Ratio is greater than Gain Therapeutics, Inc. (-5.71), less than Adagene Inc. (-1.93), less than XBiotech Inc. (-2.62), less than OS Therapies Incorporated (-0.01), greater than Nutriband Inc. (-5.53), less than Adicet Bio, Inc. (-0.43), less than NRx Pharmaceuticals, Inc. (-1.43), less than Fortress Biotech, Inc. (10.76), greater than Lite Strategy, Inc. (-4.46), greater than vTv Therapeutics Inc. (-9.22),
| Company | PE Ratio | Market cap |
|---|---|---|
| -5.71 | $126.33M | |
| -1.93 | $74.28M | |
| -2.62 | $76.52M | |
| -0.01 | $64.09M | |
| -5.53 | $56.47M | |
| -0.43 | $46.22M | |
| -1.43 | $42.18M | |
| 10.76 | $85.35M | |
| -4.46 | $64.37M | |
| -9.22 | $71.63M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like CervoMed Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like CervoMed Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is CervoMed Inc.'s PE Ratio?
How is the PE Ratio calculated for CervoMed Inc. (CRVO)?
What is the highest PE Ratio for CervoMed Inc. (CRVO)?
What is the 3-year average PE Ratio for CervoMed Inc. (CRVO)?
What is the 5-year average PE Ratio for CervoMed Inc. (CRVO)?
How does the current PE Ratio for CervoMed Inc. (CRVO) compare to its historical average?